Question 1

A drug's pKa indicates a drug's pH.

Accepted Answer

A) True 
 B)False

Question 2

Feeling physically sick after time passes since taking a chronically used drug would likely be an example of:

Accepted Answer

A)  behavior tolerance. 
B)  sensitization. 
C)  a psychological withdrawal symptom. 
D)  a physical withdrawal symptom. 
A)  behavior tolerance. 
B)  sensitization. 
C)  a psychological withdrawal symptom. 
D)  a physical withdrawal symptom.

Question 3

List and describe two approaches for reducing neurotransmission for a receptor.

Accepted Answer

A drug could be developed to a

Question 4

Mechanisms for __________________ through the blood-brain barrier consist of channels or other types proteins that transport chemicals through endothelial cell membranes.

Accepted Answer

The answer of Mechanisms for __________________ through the blood-brain barrier...

Question 5

Which of the following approaches might a pharmacologist take in order to increase concentrations of a neurotransmitter in the synaptic cleft?

Accepted Answer

A)  Develop a drug to block membrane transporters. 
B)  Develop a drug to increase catabolic enzyme activity. 
C)  Develop a drug to block calcium channels 
D)  Develop a drug to block postsynaptic receptors. 
A)  Develop a drug to block membrane transporters. 
B)  Develop a drug to increase catabolic enzyme activity. 
C)  Develop a drug to block calcium channels 
D)  Develop a drug to block postsynaptic receptors.

Question 6

A(n)__________________ is a sustained level of drug in the body.

Accepted Answer

The answer of A(n)__________________ is a sustained level of drug...

Question 7

____________ tolerance can prevent a drug from reaching its site of action.

Accepted Answer

A)  Conditioned 
B)  Behavioral 
C)  Pharmacodynamic 
D)  Pharmacokinetic 
A)  Conditioned 
B)  Behavioral 
C)  Pharmacodynamic 
D)  Pharmacokinetic

Question 8

A drug metabolite that is unable to cross the blood-brain barrier to its size likely underwent:

Accepted Answer

A)  a polymorphism process. 
B)  nonspecific binding. 
C)  Phase I biotransformation. 
D)  Phase II biotransformation. 
A)  a polymorphism process. 
B)  nonspecific binding. 
C)  Phase I biotransformation. 
D)  Phase II biotransformation.

Question 9

A(n)__________________is a drug that fully activates a neurotransmitter receptor.

Accepted Answer

The answer of A(n)__________________is a drug that fully activates a...

Question 10

When an agonist binds to a G-protein coupled receptor:

Accepted Answer

A)  a G-protein repels away neurotransmitters. 
B)  neurotransmitters enter the neuron. 
C)  no effects occur for a G-protein. 
D)  a G-protein becomes activated. 
A)  a G-protein repels away neurotransmitters. 
B)  neurotransmitters enter the neuron. 
C)  no effects occur for a G-protein. 
D)  a G-protein becomes activated.

Question 11

An increased responsiveness to a drug's effects is called sensitization.

Accepted Answer

A) True 
 B)False

Question 12

An active metabolite means that the parent drug is physiological inert.

Accepted Answer

A) True 
 B)False

A drug's pKa indicates a drug's pH.

Feeling physically sick after time passes since taking a chronically used drug would likely be an example of:

List and describe two approaches for reducing neurotransmission for a receptor.

Mechanisms for __________________ through the blood-brain barrier consist of channels or other types proteins that transport chemicals through endothelial cell membranes.

Which of the following approaches might a pharmacologist take in order to increase concentrations of a neurotransmitter in the synaptic cleft?

A(n)__________________ is a sustained level of drug in the body.

____________ tolerance can prevent a drug from reaching its site of action.

A drug metabolite that is unable to cross the blood-brain barrier to its size likely underwent:

A(n)__________________is a drug that fully activates a neurotransmitter receptor.

When an agonist binds to a G-protein coupled receptor:

An increased responsiveness to a drug's effects is called sensitization.

An active metabolite means that the parent drug is physiological inert.

Introduction to Psychopharmacology

The Nervous System

Neurotransmission

Drugs of Abuse

Psychostimulants

Nicotine and Caffeine

Alcohol

GHP and Inhalants

Opioids

Cannabinoids

Psychedelic Drugs

Treatments for Depression and Bipolar Disorder

Treatments for Anxiety Disorders

Antipsychotic Drugs

Filters

Exam 4: Properties of Drugs

A drug's pKa indicates a drug's pH.

Feeling physically sick after time passes since taking a chronically used drug would likely be an example of:

List and describe two approaches for reducing neurotransmission for a receptor.

Mechanisms for __________________ through the blood-brain barrier consist of channels or other types proteins that transport chemicals through endothelial cell membranes.

Which of the following approaches might a pharmacologist take in order to increase concentrations of a neurotransmitter in the synaptic cleft?

A(n)__________________ is a sustained level of drug in the body.

____________ tolerance can prevent a drug from reaching its site of action.

A drug metabolite that is unable to cross the blood-brain barrier to its size likely underwent:

A(n)__________________is a drug that fully activates a neurotransmitter receptor.

When an agonist binds to a G-protein coupled receptor:

An increased responsiveness to a drug's effects is called sensitization.

An active metabolite means that the parent drug is physiological inert.

Introduction to Psychopharmacology

The Nervous System

Neurotransmission

Drugs of Abuse

Psychostimulants

Nicotine and Caffeine

Alcohol

GHP and Inhalants

Opioids

Cannabinoids

Psychedelic Drugs

Treatments for Depression and Bipolar Disorder

Treatments for Anxiety Disorders

Antipsychotic Drugs

Filters